Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels

Journal of Clinical Bioinformatics

Volumn 1, Issue 1, 2011, Pages

  Rezeli, Melinda ^a   Végvári, Ákos ^a   Fehniger, Thomas E ^a,b   Laurell, Thomas ^a   Marko Varga, György ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 81455129535     PISSN: None     EISSN: 20439113     Source Type: Journal    
DOI: 10.1186/2043-9113-1-7     Document Type: Article

References (42)

1. Hood L, Heath JR, Phelps ME, Lin BY. Systems biology and new technologies enable predictive and preventative medicine. Science 2004, 306:640-643. 10.1126/science.1104635, 15499008.
2. Marko-Varga G, Lindberg H, Lofdahl CG, Jonsson P, Hansson L, Dahlback M, Lindquist E, Johansson L, Foster M, Fehniger TE. Discovery of biomarker candidates within disease by protein profiling: Principles and concepts. J Proteome Res 2005, 4:1200-1212. 10.1021/pr050122w, 16083270.
3. Prevention and Control of Chronic Respiratory Diseases at Country Level - Towards a Global Alliance against Chronic Respiratory Diseases (GARD). , http://www.who.int/respiratory/publications/WHO_NMH_CHP_CPM_CRA_05.1.pdf
4. Taylor CF, Paton NW, Lilley KS, Binz PA, Julian RK, Jones AR, Zhu WM, Apweiler R, Aebersold R, Deutsch EW, et al. The minimum information about a proteomics experiment (MIAPE). Nat Biotechnol 2007, 25:887-893. 10.1038/nbt1329, 17687369.
5. Taylor CE. Minimum reporting requirements for proteomics: A MIAPE primer. Proteomics 2006, 39-44. 10.1002/pmic.200600549, 17031795.
6. Wright JC, Hubbard SJ. Recent Developments in Proteome Informatics for Mass Spectrometry Analysis. Comb Chem High T Scr 2009, 12:194-202.
7. Orchard S, Jones A, Albar JP, Cho SY, Kwon KH, Lee C, Hermjakob H. Tackling Quantitation: A Report on the Annual Spring Workshop of the HUPO-PSI. Proteomics 2010, 10:3062-3066. 10.1002/pmic.201090075, 20806224.
8. Baker MS. Building the 'practical' human proteome project - The next big thing in basic and clinical proteomics. Curr Opin Mol Ther 2009, 11:600-602.
9. Hochstrasser D. Should the Human Proteome Project Be Gene- or Protein-centric?. J Proteome Res 2008, 7:5071-5071. 10.1021/pr800884r, 19367715.
10. A Gene-centric Human Proteome Project. Mol Cell Prot 2010, 9:427-429.
11. Atkinson AJ, Colburn WA, DeGruttola VG, DeMets DL, Downing GJ, Hoth DF, Oates JA, Peck CC, Schooley RT, Spilker BA, et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework*. Clin Pharmacol Ther 2001, 69:89-95. 10.1067/mcp.2001.113989, 11240971.
12. Marko-Varga G, Ogiwara A, Nishimura T, Kawamura T, Fujii K, Kawakami T, Kyono Y, Tu HK, Anyoji H, Kanazawa M, et al. Personalized medicine and proteomics: Lessons from non-small cell lung cancer. J Proteome Res 2007, 6:2925-2935. 10.1021/pr070046s, 17636986.
13. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921. 10.1038/35057062, 11237011.
14. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, et al. The sequence of the human genome. Science 2001, 291:1304-1351. 10.1126/science.1058040, 11181995.
15. Collins FS, Morgan M, Patrinos A. The human genome project: Lessons from large-scale biology. Science 2003, 300:286-290. 10.1126/science.1084564, 12690187.
16. Jasny BR, Roberts L. Unlocking the genome. Science 2001, 294:81-81. 10.1126/science.294.5540.81, 11588244.
17. Human Proteome Project. , http://www.hupo.org/research/hpp/HPP_Jan_25_2010.pdf
18. Hancock W, Omenn G, LeGrain P, Paik YK. Proteomics, Human Proteome Project, and Chromosomes. J Proteome Res 2011, 10:210-210. 10.1021/pr101099h, 21114295.
19. Aebersold R, Auffray C, Baney E, Barillot E, Brazma A, Brett C, Brunak S, Butte A, Califano A, Celis J, et al. Report on EU-USA Workshop: How Systems Biology Can Advance Cancer Research (27 October 2008). Mol Oncol 2009, 3:9-17. 10.1016/j.molonc.2008.11.003, 2930781, 19383362.
20. Fehniger TE, Marko-Varga G. Clinical Proteomics Today. J Proteome Res 2011, 10:3-3. 10.1021/pr1012569, 21210716.
21. Hood L. A Personal Journey of Discovery: Developing Technology and Changing Biology. Annu Rev Anal Chem 2008, 1:1-43.
22. Anderson NL. The Clinical Plasma Proteome: A Survey of Clinical Assays for Proteins in Plasma and Serum. Clin Chem 2010, 56:177-185. 10.1373/clinchem.2009.126706, 19884488.
23. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Prot 2006, 5:573-588.
24. Hu Z, Hood L, Tan O. Quantitative proteomic approaches for biomarker discovery. Proteom Clin Appl 2007, 1:1036-1041.
25. Weston AD, Hood L. Systems biology, proteomics, and the future of health care: Toward predictive, preventative, and personalized medicine. J Proteome Res 2004, 3:179-196. 10.1021/pr0499693, 15113093.
26. Lange V, Picotti P, Domon B, Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Sys Biol 2008, 4. Article number: 222.
27. Hüttenhain R, Malmström J, Picotti P, Aebersold R. Perspectives of targeted mass spectrometry for protein biomarker verification. Curr Opin Chem Biol 2009, 13:518-525. 2795387, 19818677.
28. Abbatiello SE, Mani DR, Keshishian H, Carr SA. Automated Detection of Inaccurate and Imprecise Transitions in Peptide Quantification by Multiple Reaction Monitoring Mass Spectrometry. Clin Chem 2010, 56:291-305. 10.1373/clinchem.2009.138420, 2851178, 20022980.
29. Surinova S, Schiess R, Hüttenhain R, Cerciello F, Wollscheid B, Aebersold R. On the Development of Plasma Protein Biomarkers. J Proteome Res 2011, 10:5-16. 10.1021/pr1008515, 21142170.
30. Ong SE, Schenone M, Margolin AA, Li XY, Do K, Doud MK, Mani DR, Kuai L, Wang X, Wood JL, et al. Identifying the proteins to which small-molecule probes and drugs bind in cells. Proc Natl Acad Sci USA 2009, 106:4617-4622. 10.1073/pnas.0900191106, 2649954, 19255428.
31. Finnskog D, Järås K, Ressine A, Malm J, Marko-Varga G, Lilja H, Laurell T. High-speed biomarker identification utilizing porous silicon nanovial arrays and MALDI-TOF mass spectrometry. Electrophoresis 2006, 27:1093-1103. 10.1002/elps.200500751, 16523454.
32. Klein RJ, Hallden C, Cronin AM, Ploner A, Wiklund F, Bjartell AS, Stattin P, Xu JF, Scardino PT, Offit K, et al. Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer. Cancer Prev Res 2010, 3:611-619.
33. Steuber T, Vickers AJ, Serio AM, Vaisanen V, Haese A, Pettersson K, Eastham JA, Scardino PT, Huland H, Lilja H. Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. Clin Chem 2007, 53:233-240. 10.1373/clinchem.2006.074963, 17185368.
34. Vickers AJ, Cronin AM, Roobol MJ, Savage CJ, Peltola M, Pettersson K, Scardino PT, Schroder FH, Lilja H. A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam. Clin Chem Res 2010, 16:3232-3239.
35. Végvári T, Rezeli M, Welinder C, Malm J, Lilja H, Marko-Varga G, Laurell T. Identification of Prostate Specific Antigen (PSA) Isoforms in Complex Biological Samples Utilizing Complementary Platforms. J Proteomics 2010, 73:1137-1147. 2856840, 20102753.
36. Végvári T, Rezeli M, Sihlbom C, Carlsohn E, Malm J, Lilja H, Laurell T, Marko-Varga G. Characterization of PSA in Clinical Samples by Mass Spectrometry. 4th EuPA Scientific Meeting - A Proteomics Odyssey Towards Next Decades; Estoril, Portugal 2010, 508-510. Ook-Press Ltd, Marko-Varga G, Simones T.
37. Végvári T, Marko-Varga G. Clinical Protein Science and Bioanalytical Mass Spectrometry with an Emphasis on Lung Cancer. Chem Rev 2010, 110:3278-3298.
38. Choudhary C, Mann M. Decoding signalling networks by mass spectrometry-based proteomics. Nat Rev Mol Cell Biol 2010, 11:427-439. 10.1038/nrm2900, 20461098.
39. Kiyonami R, Domon B. Selected reaction monitoring applied to quantitative proteomics. Methods Mol Biol 2010, 658:155-166. full_text, 20839103.
40. Picotti P, Rinner O, Stallmach R, Dautel F, Farrah T, Domon B, Wenschuh H, Aebersold R. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat Methods 2010, 7:43-U45. 10.1038/nmeth.1408, 19966807.
41. Zhan XQ, Desiderio DM. The human pituitary nitroproteome: detection of nitrotyrosyl-proteins with two-dimensional Western blotting, and amino acid sequence determination with mass spectrometry. Biochem Biophys Res Commun 2004, 325:1180-1186. 10.1016/j.bbrc.2004.10.169, 15555551.
42. Zhan XQ, Desiderio DM. The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomas. The EPMA Journal 2010, 1:439-459.